CCI
UTHR icon

Columbus Circle Investors’s United Therapeutics UTHR Stock Holding History

Columbus Circle Investors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-170,061
Closed -$26.6M – 312
2015
Q4 		$26.6M Buy
170,061
+29,787
+21% +$4.34M 0.21% 106
2015
Q3 		$18.4M Sell
140,274
-69,443
-33% -$11.1M 0.15% 136
2015
Q2 		$36.5M Sell
209,717
-50,289
-19% -$9.05M 0.26% 99
2015
Q1 		$44.8M Buy
260,006
+17,354
+7% +$2.65M 0.31% 84
2014
Q4 		$31.4M Buy
242,652
+150,712
+164% +$19.4M 0.22% 104
2014
Q3 		$11.8M Buy
+91,940
New +$9.48M 0.08% 188

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Columbus Circle Investors's UTHR Position: Q1 2016 in Review

Columbus Circle Investors sold out of United Therapeutics (UTHR) in Q1 2016, closing a stake of 170,061 shares — an estimated $26.6M sold.

Columbus Circle Investors first reported a position in UTHR in Q3 2014 and held it in 6 quarters. The position peaked at $44.8M in Q1 2015. 398 funds tracked by Wall St. Rank hold UTHR as of Q1 2016.

  • Columbus Circle Investors reported no remaining United Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Columbus Circle Investors sold 170,061 United Therapeutics shares in Q1 2016, an estimated $26.6M.
  • Columbus Circle Investors first reported a position in United Therapeutics in Q3 2014 and held it in 6 quarters.
  • Columbus Circle Investors's United Therapeutics position peaked at $44.8M in Q1 2015.
  • 398 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2016.

Based on Columbus Circle Investors's 13F filing for Q1 2016, filed 3 May 2016.